Wed, May 18, 2022
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022

David Westenberg Maintained (AKYA) at Buy with Decreased Target to $14 on, May 16th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-14-on-may-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $18 to $14 on, May 16th, 2022.

David has made no other calls on AKYA in the last 4 months.



There is 1 other peer that has a rating on AKYA. Out of the 1 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Monday, May 9th, 2022

Publication Contributing Sources